The outcome of various osteoprogenitor cell transplantation protocols was assessed using Col1a1-GFP reporter transgenic mice. The model requires the recipient mice undergo lethal total body irradiation (TBI) followed by rescue with whole bone marrow. When the mice are rescued with total bone marrow from a Col1a1-GFP transgenic mouse, GFP positive donor cells can be observed on most endosteal and trabecular bone surfaces. Although the cells express an osteoblast-restricted GFP, they fail to progress to osteocytes, do not form a mineralized matrix and do not generate bone nodules in vitro. However when calvarial progenitor cells derived from the same transgenic mice are injected into the bone marrow space, osteogenesis by the donor cells is observed. Using different GFP colors that distinguish the donor and recipient osteoblasts, commingling of the two cells types is observed along the mineralizing osteoblast surface as well as within the osteocyte population of the endosteal bone.
Introduction:
The effectiveness of systemic transplantation of osteoblast progenitor cells for meaningful treatment of heritable diseases of bone remains uncertain. Reports of successful engraftment after transplantation of total bone marrow 1, 2 , enriched side population cells 3 or bone marrow stromal cells in mouse [4] [5] [6] [7] [8] and human subjects 9 suggest that this strategy will ultimately be successful. These studies generally report levels of engraftment thought to be insufficient to ameliorate the underlying bone disease and are often based on criteria that do not unequivocally demonstrate that the engrafted cells are osteoblast lineage cells. The recent experience of investigators studying transplantation of myocardial 10 , neural 11 and vascular endothelial progenitor cells 12 points to the importance of a cell specific GFP reporter construct for evaluating the fate of a transplanted progenitor population. In these cases, use of a non-specific reporter such as Rosa ßgal shows engraftment by donor cells while no evidence is observed when a tissue specific GFP reporter is utilized. The conclusion suggests that many of the studies demonstrating engraftment using a tissue non-specific marker represent either a wide distribution of engrafted cells within the myeloid lineages 13, 14 or fusion of the engrafted cell with a host cell [15] [16] [17] . A similar outcome might be anticipated for transplantation of osteoblast progenitor cells.
With the development of transgenic mice each harboring different type I collagen GFP reporter constructs which mark various levels of differentiation within the osteoprogenitor lineage 18, 19 , we were in a position to evaluate various transplantation protocols with a more specific criteria for assessing outcome. The pOBCol3.6GFP transgene has been shown to activate at the preosteoblast level of differentiation and to continue to be strongly expressed in osteoblasts that line the bone surface.
However the transgene is not specific to bone and can be observed in other type I collagen producing cells such as dermal fibroblasts and smooth muscle cells. In contrast, pOBCol2.3GFP does appear to be osteoblast and osteocyte specific. The other technical development that made this transplantation study feasible was the preservation of a strong GFP signal in frozen sections of adult bone 20 .
In the study reported here, two combinations of GFP colors are utilized to distinguish either the donor and host cells or two different populations of bone lining cells within the bone. (1) Total bone marrow (TBM) derived from pOBCol3.6GFPcyan (3.6-blue) transgenic mice is systemically transplanted into a pOBCol3.6GFPtpz (3.6-green) or pOBCol2.3GFPemd (2.3-green) recipient. (2) Calvarial progenitor cells derived from a 3.6-green or 2.3-green donor mouse are mixed with TBM derived from a 3.6-blue donor mouse for direct injection into the bone marrow space of a nontransgenic recipient. Both transplantation protocols yield significant engraftment of bone lining cells, but the homing and differentiation properties are very different.
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Methods:
Transgenic mice -Established transgenic mouse lines bearing the pOBCol3.6GFPtpz (3.6-green) and pOBCol2.3GFPemd (2.3-green) expression constructs have been characterized previously 18 . A new line of mice transgenic for pOBCol3.6GFPcyan (3.6-blue) has a similar expression profile as the 3.6-green version 21 . No attempt was made to standardize the sex of the donor or recipient mice. Donor mice were approximately 2 months old while recipient mice ranged from 2 to 10 months of age but were of the same age within a specific experiment. In one series of experiments, the Col2.3 tkwere used as recipient mice. This model of conditional ablation of active osteoblasts during gangciclovir treatment has been previously described 22, 23 . The mice received 8 mg/kg/day by ip injection for 16 days and were transplanted at days 1, 7, 14, 21 and 28 after the drug was discontinued. All mice were studied on a CD1 background. Cells were introduced in a volume up to 100 µl. Local injection into the medullary space of the tibia or femur was performed in ketamine/xylazine anesthetized recipient mice. The knee was flexed to 90º
Total body irradiation (TBI) and transplantation
and the proximal end of the tibia or distal side of the femur was drawn to the anterior. A 26-gauge needle was inserted into the joint surface of the femur or tibia through the patellar tendon and then inserted into the medullary space. The needle was removed and another 26-gauge needle attached to a 1 ml syringe was inserted into the needle track and extended into the bone marrow space. Donor cells in a total volume of 30µl were slowly injected into the marrow cavity as the needle was being withdrawn from the intramedullary space. The transplanted mice were fed with regular animal chow that was not supplemented with antibiotics. Sufficient numbers of mice were subjected to this protocol so that a minimum of 3 mice would be available for sacrifice at various days after transplantation. In some experiments the mice received a 100 µl intraperitoneal injection of freshly prepared xylenol
For personal use only. on October 23, 2017 . by guest www.bloodjournal.org From orange (XO, 30 mg/ml, 90 mg/kg). The protocol for TBI and WBMT of the recipient mice and cell preparations from the donor mice was approved by the institutional animal care committee (ACC 2001-
103).
Preparation of cells for transplantation -TBM was obtained from freshly isolated femurs and tibias and placed into MEM containing 10% FBS. The cell suspension was aspirated and expelled by a syringe and 18 gauge needle, filtered through a 70 µm cell strainer, counted and centrifuged at 300g for 8 minutes. The cells were adjusted to 5.0 x 10 7 cells/ml for transplantation. Freshly isolated calvarial cells for direct transplantation were obtained from 6 day old mouse calvaria by sequential trypsin/EDTA/collagenase P digestion as previously described 18 . The pooled cell suspension from digest fractions 2-4 was passed through a 70µm cell strainer, pelleted and resuspended at a cell density of 3.0x10 7 /ml. Calvarial progenitor cells for transplantation were initiated from the freshly isolated calvarial cells that were plated at a density of 1 x 10 6 cells per 100 mm plate and grown for 5-6 days in DMEM containing 10% FBS, 100 U/ml penicillin and 100 µg/ml streptomycin. Cells at a preconfluent stage of osteoblast differentiation were harvested in 0.25% trypsin/EDTA, collected by centrifugation and resuspended in DMEM containing 10% FCS at a concentration of 3.0 x 10 7 /ml.
Analysis of the transplanted bone -Bones used for histological analysis were fixed and decalcified as previously described 21 . Decalcified and nondecalcified bones were embedded in Cryomatrix (Thermo Shandon, Pittsburgh, PA) and cryostat sections were prepared using a Leica CM1900 Cryostat (Leica The in vitro differentiation potential of the transplanted TBM or stromal cells was assessed by initiating marrow stromal cell cultures from marrow explants of the engrafted bone. The procedure was modified from a standard marrow stromal cell culture 18 to inoculate a single 35 mm well of a 6 well plate from a single femur explant. The development of donor and recipient derived bone nodules was assessed by the Axiovert/Improvision fluorescent microscope as previously described 24 .
The in vitro differentiation potential of the engrafted osteoblast population was determined by initiating osteoblast cultures from bone chips derived from the transplanted bone 25 26 . The dissected bone was cleared of adherent muscle and ligamentous attachments, opened at either end by removal of
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for 30 minutes at 37ºC with 200 rpm shaking to remove adherent cells. The chips from a single transplanted bone were placed in a 35 mm plate in 2ml of MEM containing 10% FCS, 100 U/ml penicillin, 100 µg/ml streptomycin to allow the cells within the bone to grow onto the plastic. By 10-14 days, the plastic adherent cells were harvested by trypsin digestion, separated from the remaining chips by filtration through a 70µm cell strainer filter and replated in 35 mm wells at a density of 0.5 x 10 6 cells/well. The adherent cells were expanded for 7 days in nondifferentiating medium after which they were grown in differentiating medium for 21 days 18 . The acquisition of GFP fluorescence was monitored by the Zeiss/Improvision microscope with XO staining in the late stages of the culture as discussed for the stromal cell cultures 24 .
Results:

Expression of the GFP reporter genes in the donor mice -The pattern of GFP expression
within donor bone is presented to assist in the interpretation of engrafted bone lining cells. Figure 1A illustrates 3.6-green in the osteoblastic cells that line the bone surface and extend into the outer layers of bone matrix. The low level of autofluoresence from bone marrow has a pink coloration. 2.3-green (figure 1B) is strong in cells on the bone surface and extends to most of the osteocytes within the bone matrix. Figure 1C shows 3.6-blue which is prominent in cells on the bone surface and in osteocytes near the bone surface. Figure 1D is a nondecalcified section derived from a 3.6-green mouse that was labeled with XO two days before sacrifice. This in vivo fluorescent stain will identify the surfaces of bone that are actively depositing new mineralizing osteoid. In most cases there are parallel 3.6-green and XO lines indicating that the GFP positive cells are associated with recent mineral deposition.
However there are areas of XO labeling that are not associated with the 3.6-green cells (arrows)
indicating that this marker does not identify all matrix depositing cells. Figure 5A shows that the irradiated 3.6-blue host mice do generate a limited number of 3.6-blue mineralizing nodules relative to non-irradiated controls (not shown), which is consistent with diminished marrow derived osteoprogenitor cell activity after recovery from total body irradiation 27 .
Systemic transplantation of marrow stromal cells
Even though the 3.6-blue mice can form 3.6-blue nodules after irradiation (figure 5A), there is no evidence of 3.6-blue mineralizing nodules derived from mice transplanted with total bone marrow carrying this marker gene. This observation is illustrated in figure 5B in which the host is transgenic for 2.3-green cells and 2.3-green mineralizing nodules do develop. This internal control for bone cell differentiation indicates that the culture conditions were sufficient for progenitor cells to achieve bone 
but only a few extend into the bone matrix. This pattern is consistent with the donor derived expression of 3.6-green marking early osteoblasts but not extending into mature osteocytes ( figure 1A and C) . The 3.6-green reporter transgene revealed another population of elongated fibroblastic-like cells within the bone marrow space which is never observed in the donor mouse bone ( figure 7D ). Presumably these cells represent a precursor population at a preosteoblast level of differentiation that is deposited along the needle tract (NT, figure 6B ). The 7D image suggests that osteoblastic cell differentiation occurs in cells at the perimeter of the tract.
There was no evidence for systemic engraftment by the donor progenitor cells in contrast to the TBM derived donor cells. Osteoblast differentiation was only observed in the bone that was injected. The in vitro differentiation potential of the progenitor cells that were injected into the marrow space was investigated by initiating osteoblast cultures from bone chips of the injected host bone. This protocol is designed to eliminate the bone surface or contaminating bone marrow as the source of cells that grow out from the chips 25 26 , so as to enrich for progenitor cells from within the bone matrix. The initial outgrowth cells are used to initiate a secondary culture that is grown under osteogenic conditions devoid of the chips (see methods). The presence of donor and host cells within the processed chips can be appreciated with the fluorescent microscope ( figure 8A,1 and 8A,3) . Many of the host cells that migrate from the chips to the culture dish surface continue to express a strong 3.6-green signal but not 2.3-green because they have not been induced to osteoblast differentiation. Donor derived 3.6-blue cells are evident in the initial cell outgrowth but are difficult to demonstrate at low power. During the For personal use only. on October 23, 2017. by guest www.bloodjournal.org From period when the chip-free secondary culture is grown under non-differentiating conditions, clusters of donor 3.6-blue and host 3.6-green fibroblastic like cells develop independently or in overlapping groups ( figure 8A,2) . Cultures derived from 2.3-green recipient mice did not show activity during this time ( figure 8A,4) . However 7-10 days after the culture was switched to osteogenic medium, nodules developed with strong expression of the 3.6-green, characteristic of host cells that acquire osteoblastic differentiation, and deposited mineral that stained with XO ( figure 8B 2, 3) . However the few 3.6-blue donor derived nodules that did develop failed to show XO labeling ( figure 8B 1, 4) . Because this is a secondary culture, distinct bone nodules are not as clearly defined as observed in a primary culture and regions of XO labeling develop in regions that are not obviously 3.6-green ( figure 8C 2,3) . Note the three regions of 2.3-green associated mineralization surround the cluster of 3.6-blue donor cells (figure 8C,1) that is not associated with deposited mineral ( figure 8C, 4) . Despite this problem with the culture model, the analysis indicates that the host-derived areas of strong transgene expression also deposit mineral but areas of donor derived transgene expression do not mineralize.
Discussion:
The use of cell differentiation specific GFP markers to distinguish the source and function of The results obtained in the present study may explain the results of previous reports of successful engraftment of bone surface lining cells but limited effect on bone matrix production. The donor derived cells that reside on the bone surface after total bone marrow transplantation are not osteoblasts. Although they express a promoter-GFP marker gene on the bone surface, a feature that we previously strongly associated with acquiring an osteoblast level of differentiation, it now appears that this is an improper interpretation. Three properties that would be expected of a progenitor cell with the ability to differentiate into osteoblasts were not met. First, the engrafted Col3. 6 Although host progenitor cells do survive TBI, there is a reduction in the number of nodules either due to a direct effect of the irradiation on the progenitor population or a secondary effect on the hematopoietic system which is required for osteogenic nodules to develop. In either case, the reduction of progenitor cell activity after TBI makes assessment of donor derived progenitor cells more difficult to evaluate. Despite this problem, the only mineralizing nodules that developed from TBI and whole bone marrow rescued mice developed from host progenitor cells. Thus the nature of the GFP positive cells that engraft the bone surface after systemic transplantation of total bone marrow remains uncertain.
In contrast to TBM, calvarial progenitor cells and primary calvarial digest cells are able to differentiate into osteoblasts when directly injected into the marrow space. These cells can form bone Similar to these studies, the engrafted cells appear to function locally and do not show evidence of systemic circulation either from the engrafted site or when injected systemically.
Despite the osteogenic progenitor properties of the injected progenitor calvarial cells, they do not appear to retain this attribute after transplantation. Although proliferating fibroblastic like cells of donor origin can be recovered either by explant from bone chips or by stromal cell culture of the transplanted marrow (data not shown), they can no longer generate a mineralizing bone nodule, a property that is maintained by the progenitor cells of the transplanted host. This property would suggest that the cells used in the transplantation have progressed sufficiently down the lineage to differentiate into osteoblasts when injected in sufficient numbers locally, but lose this ability to generate a mineralized nodule in vitro possibly because the early progenitors necessary for cellular expansion and differentiation no longer existed in the donor cell population.
The murine transgenic reagents to distinguish donor and host cells and the histological techniques to distinguish different colors of GFP and to colocalize them with traditional stains used in bone biology provide a rapid and unequivocal method for evaluating the differentiation potential of a progenitor population. With experience it is possible to harvest, process and evaluate the results of the transplantation experiment within 7 day after sacrifice. Although the studies reported here were performed in outbred CD1 mice requiring TBI to guard against graft rejection, it will be possible to migrate this model to inbred C57Bl/6 mice as the transgenes are developed in this mouse strain.
Identifying the optimal source of progenitor cells and transplantation protocols for successful osteoblast engraftment, either locally or systemically, will require empirically testing many experimental variables.
We believe that the methods presented in this study provide a rapid and quantitative tool for identifying robust progenitor populations and effective transplantation protocols. 5C. 5x fluorescent image of a 2.3-green nodule as seen in the 2.5x tiled image in figure 5B . The 2.3-green nodule (5C,2) shows strong mineralization (5C,3). 5C,1 shows the cluster of 3.6-blue donor derived cells (arrow heads) that happened to form adjacent to this 2.3-green nodule. It has a distinctly different morphology than the bone nodule (BN) which in this image is blue in color because the 2.3-green signal seen in figure 5C ,2 spills through the GFPcyan filter. Figure 5C4 shows the composite image of the 3.6-blue cell cluster and 2.3-green/XO bone nodule. by guest www.bloodjournal.org From above, trabecular region; 7F, below, cortical region. In both images there is commingling of 3.6-blue donor and 3.6-green host cells on the bone surface that is associated with the XO label. 
